Clinical Trial Update: DPP-4 Inhibition, Incretins and Islet Function [Phase 4]

View source ↗

Summary

A Phase 4 study from Lund University evaluated the effects of DPP-4 inhibition on incretins and pancreatic islet function in people with type 2 diabetes; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitors (class)

Snippet

Sponsor: Lund University | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED